[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.107.222. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1983

High-Dose Naloxone Infusions in NormalsDose-Dependent Behavioral, Hormonal, and Physiological Responses

Author Affiliations

From the Clinical Neuroscience Branch (Drs M. Cohen and Pickar), the Clinical Neuropharmacology Branch (Drs R. Cohen and Murphy), and the Laboratory of Psychology and Psychopathology (Dr Weingartner), National Institute of Mental Health, Bethesda, Md.

Arch Gen Psychiatry. 1983;40(6):613-619. doi:10.1001/archpsyc.1983.04390010023003
Abstract

• Hypotheses of involvement of the endogenous opioid system (EOS) in the regulation of human behavior suggest that functional blockade of the EOS should have behavioral consequences. Clinical administration of the opiate receptor antagonist naloxone hydrochloride, however, has had little or inconsistent behavioral effects in normals. This may be attributable to the use of doses insufficient to yield a complete EOS blockade. To assess this explanation, normals were administered increasing doses of naloxone hydrochloride (0.3 to 4 mg/kg) in a single-blind design. Significant dose-dependent behavioral, hormonal, and physiological effects were found. With increasing doses of naloxone, volunteers demonstrated increasingly dysphoric affects, a deterioration of performance on memory testing, increasing systolic BP and respiratory rate, and increasing plasma cortisol and growth hormone levels. These results are consistent with the expected effects of increasing EOS blockade, and thus suggest that lower doses of naloxone used in previous clinical studies may not have been sufficient to produce a complete EOS blockade. Specifically, they suggest involvement of the EOS in the tonic regulation of normal human mood, memory, BP, respirations, and plasma growth hormone and cortisol levels.

(Arch Gen Psychiatry 1983;40:613-619)

×